EG24179A - Vitronectin receptor antagonists - Google Patents

Vitronectin receptor antagonists

Info

Publication number
EG24179A
EG24179A EG20001132A EG20001132A EG24179A EG 24179 A EG24179 A EG 24179A EG 20001132 A EG20001132 A EG 20001132A EG 20001132 A EG20001132 A EG 20001132A EG 24179 A EG24179 A EG 24179A
Authority
EG
Egypt
Prior art keywords
receptor antagonists
vitronectin receptor
vitronectin
antagonists
receptor
Prior art date
Application number
EG20001132A
Other languages
English (en)
Inventor
Peter J Manley
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of EG24179A publication Critical patent/EG24179A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • External Artificial Organs (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
EG20001132A 1999-09-07 2000-09-05 Vitronectin receptor antagonists EG24179A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15278099P 1999-09-07 1999-09-07

Publications (1)

Publication Number Publication Date
EG24179A true EG24179A (en) 2008-09-28

Family

ID=22544416

Family Applications (1)

Application Number Title Priority Date Filing Date
EG20001132A EG24179A (en) 1999-09-07 2000-09-05 Vitronectin receptor antagonists

Country Status (29)

Country Link
EP (1) EP1218005B1 (tr)
JP (1) JP4685307B2 (tr)
KR (1) KR100711170B1 (tr)
CN (1) CN1236767C (tr)
AR (1) AR025589A1 (tr)
AT (1) ATE284870T1 (tr)
AU (1) AU768918B2 (tr)
BR (1) BR0013749A (tr)
CA (1) CA2384671A1 (tr)
CO (1) CO5200845A1 (tr)
CZ (1) CZ2002822A3 (tr)
DE (1) DE60016769T2 (tr)
EG (1) EG24179A (tr)
ES (1) ES2234658T3 (tr)
GC (1) GC0000203A (tr)
HK (1) HK1049110B (tr)
HU (1) HUP0202710A3 (tr)
IL (2) IL148325A0 (tr)
MX (1) MXPA02002455A (tr)
NO (1) NO322109B1 (tr)
NZ (1) NZ517296A (tr)
PE (1) PE20010582A1 (tr)
PL (1) PL200404B1 (tr)
PT (1) PT1218005E (tr)
TR (1) TR200200614T2 (tr)
TW (1) TWI255813B (tr)
UY (1) UY26329A1 (tr)
WO (1) WO2001017959A2 (tr)
ZA (1) ZA200201780B (tr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6531494B1 (en) 2001-08-29 2003-03-11 Pharmacia Corporation Gem-substituted αvβ3 antagonists
US6982263B2 (en) 2001-06-08 2006-01-03 Boehringer Ingelheim Pharmaceuticals, Inc. Nitriles useful as reversible inhibitors of cysteine proteases
GB0315509D0 (en) 2003-07-02 2003-08-06 Meridica Ltd Dispensing device
JP4853284B2 (ja) * 2004-03-05 2012-01-11 大正製薬株式会社 チアゾール誘導体
SI2593452T1 (sl) 2010-07-14 2017-06-30 Novartis Ag Heterociklične spojine agonisti receptorja IP
ES2565826T3 (es) 2012-01-13 2016-04-07 Novartis Ag Pirroles fusionados como agonistas del receptor IP para el tratamiento de hipertensión arterial pulmonar (PAH) y trastornos relacionados
WO2014125413A1 (en) 2013-02-13 2014-08-21 Novartis Ag Ip receptor agonist heterocyclic compounds
CN108675954A (zh) * 2018-04-03 2018-10-19 爱斯特(成都)生物制药股份有限公司 2-氨基-3-羟甲基吡啶的一种制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08325263A (ja) * 1995-05-31 1996-12-10 Sumitomo Metal Ind Ltd 新規2−アミノ−3−フェニルプロピオン酸誘導体
JPH08325264A (ja) * 1995-05-31 1996-12-10 Sumitomo Metal Ind Ltd 新規2−芳香環置換−3−フェニルプロピオン酸またはアクリル酸誘導体
KR19990076876A (ko) * 1995-12-29 1999-10-25 스티븐 베네티아너 비트로넥틴 수용체 길항제
AU8750298A (en) * 1997-08-28 1999-03-22 Ono Pharmaceutical Co. Ltd. Peroxisome proliferator-activated receptor controllers
AR015446A1 (es) * 1997-09-19 2001-05-02 Smithkline Beecham Corp Antagonistas de receptores de vitronectina, composicion farmaceutica que los contiene, procedimiento para su preparacion, su uso para la elaboracion de unmedicamento y compuestos intermediarios
EA200000921A1 (ru) * 1998-03-10 2001-04-23 Смитклайн Бичам Корпорейшн Антагонисты рецептора витронектина
WO2000009503A1 (en) * 1998-08-13 2000-02-24 Merck & Co., Inc. Integrin receptor antagonists

Also Published As

Publication number Publication date
ZA200201780B (en) 2003-05-28
EP1218005A2 (en) 2002-07-03
UY26329A1 (es) 2001-07-31
WO2001017959A2 (en) 2001-03-15
GC0000203A (en) 2006-03-29
NO20021113L (no) 2002-05-03
AU768918B2 (en) 2004-01-08
CO5200845A1 (es) 2002-09-27
NZ517296A (en) 2003-11-28
JP2003508516A (ja) 2003-03-04
IL148325A (en) 2007-06-03
PT1218005E (pt) 2005-05-31
WO2001017959A3 (en) 2001-05-10
IL148325A0 (en) 2002-09-12
NO322109B1 (no) 2006-08-14
HK1049110B (zh) 2005-07-22
HUP0202710A3 (en) 2003-06-30
EP1218005A4 (en) 2002-10-09
TWI255813B (en) 2006-06-01
AU7354300A (en) 2001-04-10
CN1236767C (zh) 2006-01-18
NO20021113D0 (no) 2002-03-06
HUP0202710A2 (hu) 2002-12-28
CA2384671A1 (en) 2001-03-15
EP1218005B1 (en) 2004-12-15
PL354176A1 (en) 2003-12-29
ATE284870T1 (de) 2005-01-15
PE20010582A1 (es) 2001-06-23
HK1049110A1 (en) 2003-05-02
AR025589A1 (es) 2002-12-04
CN1377269A (zh) 2002-10-30
TR200200614T2 (tr) 2002-07-22
ES2234658T3 (es) 2005-07-01
DE60016769T2 (de) 2005-11-24
PL200404B1 (pl) 2009-01-30
DE60016769D1 (de) 2005-01-20
KR100711170B1 (ko) 2007-04-27
KR20020027624A (ko) 2002-04-13
CZ2002822A3 (cs) 2002-07-17
JP4685307B2 (ja) 2011-05-18
BR0013749A (pt) 2003-06-10
MXPA02002455A (es) 2002-07-02

Similar Documents

Publication Publication Date Title
EP1000031A4 (en) VITRONECTIN RECEPTOR ANTAGONISTS
IL130760A0 (en) Vitronectin receptor antagonists
EP1194151A4 (en) ANTAGONISTS OF THE INTEGRIN RECEPTORS
EP1229910A4 (en) integrin
IL138245A0 (en) Vitronectin receptor antagonists
IL135189A0 (en) Vitronectin receptor antagonist
IL135028A0 (en) Vitronectin receptor antagonists
IL135188A0 (en) Vitronectin receptor antagonist
IL148043A0 (en) Novel integrin receptor antagonists
EG24025A (en) Vitronectin receptor antagonist
EG24179A (en) Vitronectin receptor antagonists
IL146146A0 (en) Integrin receptor antagonists
IL141163A0 (en) Vitronectin receptor antagonists
GB9822331D0 (en) Vitronectin receptor antagonists
GB9807384D0 (en) Vitronectin receptor antagonists
GB9810182D0 (en) Vitronectin receptor antagonists
GB9810882D0 (en) Vitronectin receptor antagonists
GB9807382D0 (en) Vitronectin receptor antagonists
GB9810892D0 (en) Vitronectin receptor antagonists
GB9811295D0 (en) Vitronectin receptor antagonists
GB9812686D0 (en) Vitronectin receptor antagonists
GB9815803D0 (en) Vitronectin receptor antagonists
SI1187592T1 (sl) Antagonisti alfa V integrinskega receptorja
ZA988562B (en) Vitronectin receptor antagonists
ZA991884B (en) Vitronectin receptor antagonists.